Need all Congresses? Press Enter for expanded federal results.

Drug safety, medical device, and laboratory regulation

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
305
Coverage
110th-119th
Current view
116th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
305 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 6901
COVID–19 Testing Inventory Act
116th Referred to the House Committee on Energy and Commerce. May 15, 2020
HR 6885
Safe and Secure Medicine Supply for Hardworking Americans Act of 2020
116th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. May 15, 2020
HR 6863
COVID–19 Accountability Act
116th Referred to the Committee on Foreign Affairs, and in addition to the Committees on the Judiciary, Financial Services, Ways and Means, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. May 14, 2020
HR 6858
COVID–19 Emergency Medical Supplies Enhancement Act of 2020
116th Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. May 13, 2020
HR 6839
To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVI...
116th Referred to the House Committee on Energy and Commerce. May 12, 2020
HR 6829
EMPIL–DOC Act
116th Referred to the House Committee on Energy and Commerce. May 12, 2020
HR 6708
Securing America’s Medicine Cabinet Act of 2020
116th Referred to the House Committee on Energy and Commerce. May 5, 2020
HR 6670
Prescription for American Drug Independence Act of 2020
116th Referred to the House Committee on Energy and Commerce. May 1, 2020
HR 6660
LOSS Act of 202
116th Referred to the House Committee on Energy and Commerce. May 1, 2020
HR 6482
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
116th Referred to the Subcommittee on Oversight and Investigations. July 13, 2020
HR 6396
Responsible Relief for Americans Act
116th Referred to the Subcommittee on Health. September 30, 2020
HR 6282
Commission on America’s Medical Security Act
116th Referred to the House Committee on Energy and Commerce. March 13, 2020
HR 6260
Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020
116th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. March 12, 2020
HR 6258
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2020
116th Referred to the House Committee on Energy and Commerce. March 12, 2020
HR 6238
Cameron’s Law
116th Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. March 12, 2020
HR 6155
To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biolog...
116th Referred to the House Committee on Energy and Commerce. March 9, 2020
HR 6102
VALID Act of 2020
116th Referred to the House Committee on Energy and Commerce. March 5, 2020
HR 6062
To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the pro...
116th Sponsor introductory remarks on measure. (CR H1476) March 4, 2020
HR 6049
Medical Supply Chain Security Act
116th Referred to the House Committee on Energy and Commerce. March 2, 2020
HR 6019
Cure the Coronavirus Act
116th Referred to the House Committee on Energy and Commerce. February 28, 2020
HR 5986
Environmental Justice For All Act
116th Committee Hearings Held. October 1, 2020
HR 5982
Safe Medicine Act
116th Referred to the House Committee on Energy and Commerce. February 26, 2020
HR 5966
Restore and Modernize Our National Labs Act
116th Referred to the House Committee on Science, Space, and Technology. February 25, 2020
HR 5927
Safe Medicine Act
116th Referred to the House Committee on Energy and Commerce. February 18, 2020
HR 5894
Transparency in Prescription Drug Advertising Act
116th Referred to the House Committee on Energy and Commerce. February 13, 2020
HR 5882
GENE Therapy Payment Act
116th Referred to the House Committee on Energy and Commerce. February 12, 2020
HR 5774
Veterans HOPE Act
116th Referred to the Subcommittee on Health. March 2, 2020
HR 5668
MODERN Labeling Act of 2020
116th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. November 18, 2020
HR 5663
Safeguarding Therapeutics Act
116th Became Public Law No: 116-304. January 5, 2021
HR 5632
FDA Accountability for Public Safety Act
116th Referred to the House Committee on Energy and Commerce. January 16, 2020
HR 5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived can...
116th Referred to the Subcommittee on Biotechnology, Horticulture, and Research. January 23, 2020
HR 5578
Recall Unsafe Drugs Act of 2020
116th Referred to the House Committee on Energy and Commerce. January 10, 2020
HR 5501
Affordable Drug Manufacturing Act of 2019
116th Referred to the Subcommittee on Health. December 20, 2019
HR 5497
Conditional Approval Act
116th Referred to the Subcommittee on Health. December 20, 2019
HR 5482
PREVENT Act of 2020
116th Referred to the Subcommittee on Health. December 19, 2019
HR 5480
ALS Placebo No More Act
116th Referred to the Subcommittee on Health. December 19, 2019
HR 5444
Lower Insulin Costs Now Act
116th Referred to the Subcommittee on Health. December 18, 2019
HR 5402
Protecting America’s Life Saving Medicines Act of 2019
116th Referred to the Subcommittee on Health. December 12, 2019
HR 5400
National Biomedical Research Act
116th Referred to the Subcommittee on Health. December 12, 2019
HR 5381
International Pharmaceutical Transparency Act of 2019
116th Referred to the Subcommittee on Health. December 11, 2019